In the biotech field, alongside the widely recognized industry giants, some relatively smaller companies focused on specific niches are also demonstrating considerable potential through solid R& ...

Dallas is focusing on new and advanced treatments, like those that use cells or genes. They are also looking at how biology ...

TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing ...

Guided by the "Healthy China 2030" strategy, governments, institutions, and enterprises are jointly investing in the health industry, continuously raising residents' health awareness. With the ...

The SBIO ETF has staged a remarkable comeback, outperforming despite a challenging macro backdrop and small-cap weakness.

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic ...

HK Innoen announced on the 26th that it received the highest grade (AA) in the "2025 Second Half ESG Evaluation Results" ...

The global bioreactor market is projected to grow at a compound annual growth rate (CAGR) of around 7%, driven by the rising ...

On November 20, 2025, at a closed-door, Q&A webinar on the proposed BIOSECURE Act, Joy Sturm, partner in the Hogan Lovells government ...

Urban areas face unprecedented challenges due to climate change, biodiversity loss, and rapid population growth. In this ...

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or ...

Every year, the fields of fisheries and aquaculture generate substantial quantities of leftover biomass, including heads, ...